Idiopathic pulmonary arterial hypertension
Information
- Disease name
- Idiopathic pulmonary arterial hypertension
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02565030 | Completed | Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome | February 2015 | October 2021 | |
| NCT00257413 | Completed | N/A | Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension | ||
| NCT00626028 | Completed | Phase 3 | Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing | September 2004 | February 2010 |
| NCT00641836 | Completed | N/A | Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension | July 2005 | December 2007 |
| NCT05767918 | Completed | StratosPHere (Non-interventional Study) | April 14, 2021 | September 30, 2022 | |
| NCT03069716 | Completed | N/A | A Mobile Health Intervention in Pulmonary Arterial Hypertension | August 2, 2017 | April 24, 2020 |
| NCT01590108 | Completed | Phase 1 | The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy Subjects | March 2012 | September 2014 |
| NCT01613287 | Completed | N/A | Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension | June 2012 | November 2013 |
| NCT02790450 | Completed | Phase 2 | Acute Effects of Benzbromaron on the Pulmonary Circulation | October 2015 | August 2016 |
| NCT06104228 | Not yet recruiting | Phase 2 | 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH) | July 1, 2024 | March 31, 2026 |
| NCT05462574 | Recruiting | Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH) | January 17, 2023 | September 30, 2027 | |
| NCT05493371 | Recruiting | Phase 2 | Empagliflozin in Pulmonary Arterial Hypertension | March 1, 2023 | November 1, 2024 |
| NCT05584722 | Recruiting | Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals | November 1, 2022 | August 31, 2026 | |
| NCT01884051 | Recruiting | Hormonal, Metabolic, and Signaling Interactions in PAH | September 2012 | July 2032 | |
| NCT03933579 | Unknown status | The PAH Platform for Deep Phenotyping in Korean Subjects | March 1, 2018 | December 31, 2020 | |
| NCT01246037 | Unknown status | Phase 1/Phase 2 | Beta-blockers in i-PAH | February 2011 | April 2014 |
| NCT00372346 | Unknown status | N/A | Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension | June 2006 | December 2007 |
| NCT01683981 | Unknown status | Early Phase 1 | Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline Malate | August 2012 | August 2013 |
| NCT02959723 | Unknown status | Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies | January 2015 | December 2020 | |
| NCT01288651 | Unknown status | Phase 4 | Iron Deficiency In Pulmonary Hypertension | January 2011 | January 2013 |
| NCT01645826 | Withdrawn | N/A | Efficacy Study of Cardizem in Pulmonary Arterial Hypertension | July 2012 | September 2014 |
- OrphaNumber from OrphaNet (Orphanet)
- 275766